The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 20th 2024
Aflibercept-jbvf (Yesafili; Biocon Biologics) and aflibercept-yszy (Opuviz; Biogen) are the first interchangeable biosimilars to aflibercept (Eylea; Regeneron).
Merck Announces Initiation of Clinical Development for Investigational HPV Vaccine
March 21st 2024Merck will also conduct clinical trials in both males and females to evaluate the efficacy of a single dose of their current human papillomavirus vaccine compared with the approved 3-dose regimen.
Read More